Marco Prunotto

Marco is a Venture Partner at Medicxi. Prior to joining Medicxi, Marco was Global Head of Technology and translational research at Roche Pharma I20 development where he was part of the leadership team. He previously served as Head of Translational Research at Galapagos NV. Prior to that he served in several roles within the discovery organisation of Roche pRED in Basel. He created and led the phenotypic drug discovery unit and led the nephrology discovery team.

Marco received a PhD in Biotechnology from the University of Turin and conducted postdoctoral research at the University of Geneva. Marco also serves as senior lecturer at the School of Pharmaceutical Sciences of the University of Geneva.